CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
出版年份 2022 全文链接
标题
CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
作者
关键词
-
出版物
Alzheimers & Dementia
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-02-28
DOI
10.1002/alz.12570
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter
- (2021) Alexis Moscoso et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
- (2021) Alexis Moscoso et al. JAMA Neurology
- Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
- (2021) Sarah K. Royse et al. Alzheimers Research & Therapy
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Predicting future rates of tau accumulation on PET
- (2020) Clifford R Jack et al. BRAIN
- Association is not prediction: a landscape of confused reporting in diabetes – a systematic review
- (2020) Tibor V. Varga et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- White matter hyperintensities are associated with subthreshold amyloid accumulation
- (2020) Alexis Moscoso et al. NEUROIMAGE
- Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment
- (2020) David S. Knopman et al. JAMA Neurology
- The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
- (2020) Ruben Smith et al. BRAIN
- Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
- (2020) Alexis Moscoso et al. BRAIN
- Longitudinal tau accumulation and atrophy in aging and alzheimer disease
- (2019) Theresa M. Harrison et al. ANNALS OF NEUROLOGY
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
- (2019) Rik Ossenkoppele et al. NEUROLOGY
- A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
- (2019) Michael J Pontecorvo et al. BRAIN
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Tau-positron emission tomography correlates with neuropathology findings
- (2019) Val J. Lowe et al. Alzheimers & Dementia
- Establishment of Best Practices for Evidence for Prediction
- (2019) Russell A. Poldrack et al. JAMA Psychiatry
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?
- (2018) Oskar Hansson et al. BRAIN
- Longitudinal tau PET in ageing and Alzheimer’s disease
- (2018) Clifford R Jack et al. BRAIN
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
- (2018) Renaud La Joie et al. Alzheimers & Dementia
- AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
- (2017) Shruti Mishra et al. NEUROIMAGE
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
- (2015) William J. Jagust et al. Alzheimers & Dementia
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
- (2015) Ju-Hee Kang et al. Alzheimers & Dementia
- Cortical tau load is associated with white matter hyperintensities
- (2015) Kirsty E. McAleese et al. Acta Neuropathologica Communications
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started